The influenza parainfluenza viruses
1 / 35

The Influenza & Parainfluenza viruses - PowerPoint PPT Presentation

  • Uploaded on

The Influenza & Parainfluenza viruses. Orthomyxoviridae & Paramyxoviridae. Classification. ORTHOMYXOVIRIDAE. Influenza viruses. Type A. Type B. Type C. Family:. Genus:. Types:. “ myxo ” refers to interaction with mucins (glycoproteins)

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'The Influenza & Parainfluenza viruses' - bonita

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
The influenza parainfluenza viruses

The Influenza &Parainfluenza viruses

The influenza parainfluenza viruses






Influenza viruses

Type A

Type B

Type C




The influenza parainfluenza viruses

  • myxo” refers to interaction with mucins (glycoproteins)

  • Different from paramyxoviruses : -segmented genome

  • - smaller (average 110 nm in diameter against 150 nm).

An enveloped viruse helical symmetry capsid segmented linear rna genome
An envelopedviruse, helicalsymmetrycapsid, segmentedlinear RNA genome


Nucleoprotein (7 or 8 RNA segments)



Matrix protein (M)

Lipid bilayer

Haemaglutinin (HA)



Neuraminidase (NA)

80 to 120 nm

The influenza parainfluenza viruses

Each hemagglutinin spike is made up of three entwined molecules while each neuraminidase is comprised of four entwined molecules.

On the surface of the virus are M2 proteins. Inside the lipid envelope, there are eight RNA gene segments called RNPs(RNA molecule+ Nucleoprotein+ Polymerases).

Ball shaped M1 proteins: as cushions for the RNPs inside.

Surface glycoproteins
Surface glycoproteins


H or HA

responsible for pathogenicity of the virus

allows virus to adhere to endothelial cells in the respiratory tract

main determinant of immunity


N or NA

allows release of newly formed viruses within host

determinant of disease severity

The influenza parainfluenza viruses

Antibody against the hemagglutininneutralizes the infectivity of the virus and prevents disease. Ab against neuraminidase only reduces disease.

Influenza subgroups
Influenza subgroups

Influenza A

highly infective

infects many species

causes widespread epidemics

Influenza B

found only in humans

capable of producing severe disease

causes regional epidemics

Influenza C

causes mild disease

humans are natural hosts, but isolates also found in pigs

does not cause epidemics

The influenza parainfluenza viruses

  • Reassortment of segments of the genome RNA

  • Influenza viruses, especially type A show changes in the antigenicity of their hemagglutinin and neuraminidase proteins.  epidemics.

  • Influenza viruses antigenes

  • Group-specific (internal ribonucleoprotein) antigenes.

  • Type-specific (surface N and H) antigens.

The influenza parainfluenza viruses

Many species of animal (eg. Birds, swine, and hourses) have their own influenza A viruses.

These animal viruses are probably the source of the new antigenic types.

Antigenic shift: Major changes based on reassortment of genome pieces. Occurs every 10-11 years

Antigenic drift: Minor changes based on mutation occurs every year.

The influenza parainfluenza viruses

The influenza parainfluenza viruses

Epidemics and pandemics of human with animal or bird ,providing major antigenic change.This can cause a major epidemic or pandemic involving most or all age groups.occur when the antigenicity of the virus has changed sufficiently that the preexisting immunity of many people is no longer effective.

The influenza parainfluenza viruses

Various combinations of RNA segments can result in a new subtype of virus (known as antigenic shift

It is even possible to include RNA strands from birds, swine, and human influenza viruses into one virus if a cell becomes infected with all three types of influenza.

Occurrence of influenza a viruses
Occurrence of influenza A viruses subtype of virus

Influenza A viruses 16 HA types

9 NA types

Species affected humans, pigs, horses, birds, marine mammals

In humans 3 HA types (H1, H2, H3)

3 NA types (N1, N2, N8)

In birds all HA types

all NA types

Influenza viruses nomenclature
Influenza viruses nomenclature subtype of virus

For example:

A / Beijing / 32 / 92 (H3N2)

A virus type, here A

Beijing place where the strain was isolated

32 strain number

92 year of first isolation

H3N2 subtypes H3 and N2 virus sub type, here H3N2

The influenza parainfluenza viruses

Pathogenesis subtype of virus

After the virus is inhaled, the neuraminidase degrades the protective mucus layer, allowing the virus to gain access to the cells of the upper and lower respiratory tract.

Viremia rarely occurs, but there is necrosis of the superficial layers of respiratory epithelium.

The influenza parainfluenza viruses

Immunity subtype of virus

Circulating IgG against the virus occurs after infection, but offers little protection. Secretory IgA in the respiratory tract is protective.

The influenza parainfluenza viruses

  • Clinical findings subtype of virus

  • Incubation period: 24-48 hours

  • Symptoms: fever, myalgias, headache, cough develop suddenly.

  • The symptoms resolve spontaneously in 4-7 days but sometimes is complicated with secondary infections.

  • Rey’s syndrome (Encephalopathy and liver degeneration life-threatening complication in children) following some viral infections, particularly influenza B and chikenpox, if they have been given Asprin to reduce the fever.

COMPLICATIONS subtype of virus

  • Pneumonia

  • Respiratory failure

  • Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

When to seek emergency medical care
When to Seek Emergency Medical Care subtype of virus

  • has difficulty breathing or chest pain

  • has purple or blue discoloration of the lips

  • is vomiting and unable to keep liquids down

  • has signs of dehydration such as dizziness when standing, absence of urination, or in infants, a lack of tears when they cry

  • has seizures (for example, uncontrolled convulsions)

  • is less responsive than normal

Risk groups
RISK GROUPS subtype of virus

  • Persons with certain chronic medical condition

  • School children

  • Travelers to some high risk places

  • Border workers

  • Health care workers or public health workers

PREVENTION subtype of virus

  • Prevention in swine or other animal hosts.

  • Prevention of transmission to humans.

  • Prevention of its spread among humans.

Prevention of its spread among humans

Frequent washing of hands with soap and water subtype of virus

Prevention of its spread among humans.

The influenza parainfluenza viruses

Use of face masks subtype of virus

The influenza parainfluenza viruses

Use of subtype of virus

towel while sneezing

The influenza parainfluenza viruses

Lab diagnosis subtype of virus

  • Virus isolation (by throat washing) with cell culture. Then flurescent-antibody staining of the infected cells by using antisera to influenza A and B.

  • A rise in antibody titer of at least 4-fold in serum samples using hemmagglutination inhibition or complement fixation.

  • PCR reactions

TREATMENT subtype of virus

  • supportive care is required. Bed Rest

  • Keep the sick person in a room separate from the common areas of the house.

  • Antibiotics (to treat this disease, do help prevent bacterial pneumonia and other secondary infections.)

  • Viral agent is used in severe infections.

    (Zanamivir orTamiflu is recommended by C.D.C.)

VACCINE subtype of virus

  • The current trivalent influenza vaccine is likely to provide protection against the new 2009 H1N1 strain.